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Abstract
Background
Guidelines for management of the second stage have been proposed since the 1800s
and were created largely by expert opinion. Current retrospective data are mixed
regarding differences in maternal and neonatal outcomes with a prolonged second
stage. There are no randomized controlled trials that have evaluated whether extending
the second stage of labor beyond current American College of Obstetricians and
Gynecologists recommendations is beneficial.

Objective
The purpose of this study was to evaluate whether extending the length of labor in
nulliparous women with prolonged second stage affects the incidence of cesarean
delivery and maternal and neonatal outcomes.

Study Design
We conducted a randomized controlled trial of nulliparous women with singleton
gestations at 36 0/7 to 41 6/7 weeks gestation who reached the American College of

Obstetricians and Gynecologists definition of prolonged second stage of labor, which is
3 hours with epidural anesthesia or 2 hours without epidural anesthesia. Women were
assigned randomly toextended labor for at least 1 additional hour, or to usual labor,
which was defined as expedited delivery via cesarean or operative vaginal delivery. The
exclusion criteria were intrauterine fetal death, planned cesarean delivery, age <18
years, and suspected major fetal anomaly. Primary outcome was incidence of cesarean
delivery. Maternal and neonatal outcomes were compared secondarily. Statistical
analysis was done by intention-to-treat.

Results
Seventy-eight nulliparous women were assigned randomly. All of the women had
epidural anesthesia. Maternal demographics were not significantly different. The
incidence of cesarean delivery was 19.5% (n = 8/41 deliveries) in the extended labor
group and 43.2% (n = 16/37 deliveries) in the usual labor group (relative risk, 0.45; 95%
confidence interval, 0.22–0.93). The number needed-to-treat to prevent 1 cesarean
delivery was 4.2. There were no statistically significant differences in maternal or
neonatal morbidity outcomes.

Conclusion
Extending the length of labor in nulliparous women with singleton gestations, epidural
anesthesia, and prolonged second stage decreased the incidence of cesarean delivery
by slightly more than one-half, compared with usual guidelines. Maternal or neonatal
morbidity were not statistically different between the groups; however, our study was
underpowered to detect small, but potentially clinical important, differences.

Introduction

Guidelines for the management of the second stage of labor have been proposed since
the 1800s and were created largely by expert opinion. The first large retrospective data
collection was done by Hellman and Prystowsky1 in 1952, which showed that women
who had a second stage of labor within 2 hours had a decreased rate of postpartum
hemorrhage, fever, and neonatal death. Friedman,3 in 1955, evaluated the natural
course of labor and noted that most nulliparous women without epidural anesthesia
delivered within 2 hours.2Recent data have suggested that obstetricians may want to
extend the time limit to 3 hours to achieve a vaginal delivery for nulliparous women
without an epidural and to 4 hours in those with an epidural. However, current
retrospective data are mixed regarding differences in maternal and neonatal outcomes
with a prolonged second stage.4, 5, 6 and 7 There are no randomized controlled trials that

have evaluated whether extending the second stage of labor beyond current American
College of Obstetricians and Gynecologists (ACOG) recommendations is beneficial.8
The aim of this study was to evaluate whether extending the time limit of second stage
of labor beyond current ACOG guidelines would affect the incidence of cesarean
delivery (CD). Maternal and perinatal outcomes were also assessed.

Materials and Methods
This study was conducted from March 2014 until July 2015 at Thomas Jefferson
University Hospital. The protocol was approved by the institutional review board, and all
women provided written informed consent before assignment. Eligible nulliparous
women were at least 18 years old with singleton pregnancies of at least 36 weeks
gestation, cephalic presentation, and category I or II fetal heart tracings. Exclusion
criteria included category III fetal heart tracing, previous vaginal delivery at ≥24 weeks
gestation, multiple pregnancy, intrauterine fetal death, trial of labor after CD, planned
CD, or suspected major fetal anomaly. Women were consented well before the second
stage started, either in the office during prenatal care or early on admission to labor and
delivery. Participating women did not receive compensation.
This study was a randomized controlled trial. Randomization was completed by a
computer-generated list that used random block sizes of 8, 10, and 12. Group
assignments were made based on sequentially numbered opaque sealed envelopes.
The sequence was generated by the primary investigator (A.C.G.). Participants were
consented by labor and delivery providers in the office or on admission. Women were
assigned randomly to either “extended care” or “usual care” groups. Randomization was

stratified by epidural status. Suggested treatment for women who were assigned
randomly to the extended care group was continuing the second stage for at least 1
additional hour after reaching the ACOG prolonged second stage criteria (ie, after 3
hours in the second stage of labor with an epidural or 2 hours without an epidural).
Suggested treatment for women who were assigned randomly to the usual care group
was delivery soon after reaching the criteria for prolonged second stage listed by
ACOG. Women were assigned randomly by labor and delivery staff at either the 3-hour
mark (with epidural) or 2-hour mark (without epidural).
Except for the suggested management regarding length of the second stage as per
randomization, the second stage of labor was managed according to the individual
provider on labor and delivery. All patients were treated by house staff under the
supervision of an attending physician. In general, on the finding of complete dilation,
women without an urge to push were offered delayed pushing (ie, waiting about 1 hour
before starting to push). Once pushing started, this usually was done via Valsalva
maneuver. Delayed pushing was included in the total time of second stage. After
reaching ACOG criteria for prolonged second stage, women in the extended care group
were given at least 1 additional hour to have a spontaneous vaginal delivery (SVD) then
delivered by the labor and delivery team with the option of CD, forceps-assisted vaginal
delivery (FAVD), or vacuum-assisted vaginal delivery (VAVD). Women in the usual care
group who reached ACOG criteria for prolonged second stage were at that point
expeditiously delivered by the labor and delivery team with the option of CD, FAVD, or
VAVD.

Primary outcome was CD. Maternal secondary outcome measures included incidence
of: vaginal delivery (SVD and operative vaginal delivery [OVD] combined), SVD, OVD,
chorioamnionitis, endometritis, postpartum hemorrhage (defined as >500 mL estimated
blood loss in a vaginal delivery and >1000 mL estimated blood loss in a CD),
transfusion, third- and fourth-degree laceration, and cervical laceration.
Neonatal secondary outcome measures included shoulder dystocia, birthweight,
neonatal intensive care unit (NICU) admission, ventilation support with the use of
continuous positive airway pressure or greater, sepsis, seizure, umbilical artery cord
pH <7.10, perinatal death, and NICU length of stay.
Race/ethnicity was classified by the study participants. The classifications were nonHispanic white, non-Hispanic black, Asian, Hispanic, or other.
A priori sample size estimation was calculated with an α of .05 and β of .20. Based on
observations of successful vaginal delivery at 4-hour second stage by Mentigoglu
et al,9 and on more recent delivery rates at our institution, we estimated that the CD rate
in the usual care group (ie, soon after 3 hours with an epidural or 2 hours without an
epidural) would be 50%, with a reduction to 20% at 4 hours with an epidural or 3 hours
without an epidural. A total sample of 78 women was estimated to provide 80% power
to detect a >2-fold decrease in CD rate. A subgroup analysis was planned for women
with an epidural vs women without an epidural. Potential confounders were planned to
be analyzed to determine confounding vs interaction.
The data analysis for this study was generated with SPSS software (version 20; IBM,
Armonk, NY). Statistical analysis was performed by the intention-to-treat principle.
Categorical variables were compared with the use of χ2 test or Fisher exact test.

Continuous variables were compared with the use of 2-tailed Student t test or Wilcoxon
Rank-Sum test. A probability value of <.05 was considered statistically significant. Data
were analyzed by the primary investigator (A.C.G.) with assistance from the Thomas
Jefferson University Biostatistics Department.
The Consolidated Standards of Reporting Trials guidelines were followed. 10 This trial
was registered on clinicaltrials.gov (NCT02101515). This study was not funded.

Results
From March 2013 through July 2015, we enrolled 78 nulliparous women, of whom 41
women were assigned to receive extended labor and 37 women were assigned to usual
labor. No women were excluded or lost to follow up. All had epidural anesthesia. All
women initially received the allocated intervention; however, there was a 14.1%
crossover rate (extended labor, 2; usual labor, 9). Reasons for crossover in the
extended labor group were maternal request (n = 1) and nonreassuring fetal heart
tracing (n = 1). Reasons for crossover in the usual labor group included maternal
request (n = 4) and delivery provider decision (n = 5). No women withdrew from the
study. There was no loss to follow up. Figure 1 shows the trial flow diagram.
Figure options

Overall, the women were 44.9% white and 25.6% African American. The average body
mass index was 30.9 kg/m2; 100% of the women had an epidural, and 48.7% of the
women had labor induced. Maternal demographics were not significantly different,
except for insurance type (P = .03) and occiput posterior presentation (P = .03; Table 1).

There was 1 failed OVD in the extended labor group and 4 failed OVDs in the usual
labor group (P = .3). All failed OVDs were VAVDs.
Maternal outcome measures including chorioamnionitis, endometritis, postpartum
hemorrhage, transfusion, third-- or 4th-degree perineal lacerations, and cervical
lacerations, did not differ between groups (Table 2). There were no differences in
neonatal morbidity outcomes between groups (Table 3).

The average time after randomization was 92 ± 65 minutes in the extended labor group
and 78 ± 46 minutes in the usual labor group (P = 0.3).
Subgroup analysis was performed for fetal position. In the extended labor group,
women with fetuses in the occiput posterior position had a similar risk of CD compared
to the usual labor group (RR 1.60; 95% CI 0.92–2.81). In comparison, in the extended
labor group, women with fetuses in the occiput anterior position had significantly
decreased risk of CD compared to the usual labor group (RR 0.17; 95% CI 0.04–0.75).
Additionally, women in the extended labor group who underwent an induction of labor
had no difference in risk of CD (RR 0.84; 95% CI 0.32–2.05) compared to the usual
labor group. However, women in the extended labor group who presented in
spontaneous labor had a significantly decreased risk of CD (RR 0.11; 95% CI 0.01–
0.78) compared to the usual labor group.

Comment
In this trial of nulliparous women with epidural anesthesia and prolonged (≥3 hours)
second stage of labor, extending the second stage of labor decreases the incidence of

CD by a significant percentage (55%) compared with usual labor guidelines, from 43.2%
with usual labor to 19.5% with extended labor. Importantly, the decrease in CD was
obtained without increasing maternal or neonatal morbidity. The number needed-to-treat
to prevent 1 CD in this cohort of women was 4.2.
There are several strengths of this study. First, the trial was designed as a randomized
controlled trial with an intention-to-treat analysis, and recruitment of the desired women
was completed. Second, there are no similar trials in the literature on this subject. Third,
there was no loss to follow up. Fourth, there were no changes to the protocol during the
trial. Fifth, the estimated incidence of CD of the extended labor group that we used for
our power calculations was very similar as in the population that was studied. Last,
recruitment was relatively easy for this study; consents were obtained from 87.3% of the
women who were approached, which suggests that most women are highly motivated
to have an SVD.
Although we reached our pretrial goal for sample size, a potential limitation of this study
was the relatively small number of women who were included. Although no maternal
morbidity differences were found, postpartum hemorrhage, endometritis, and third- and
fourth-degree lacerations all had wide confidence intervals. This study was
underpowered to determine differences in these outcomes. Additionally, the time
difference between the 2 groups was not statistically significantly different 92 ± 65
minutes vs 78 ± 46 minutes; P = .3). The lack of time difference was contributed
by several factors that included the 14.1% overall crossover, time spent waiting for
operating rooms to be available, and time waiting to set up for an OVD. Nevertheless,
the lack of time difference and the presence of crossover strengthen our results

because of the analysis as intention-to-treat. It was the intention of extending the
second stage of labor to at least 4 hours that seemed to have contributed to the results.
The generalizability of this study was limited by the fact that no women without an
epidural were assigned randomly. Out of the entire cohort of nulliparous women who
presented to labor and delivery during the study time period and did not have an
epidural, only 4 of 107 women (3.7%) had prolonged second stage >2 hours. Of these 4
women, none was consented for the trial. This is an important finding because it
supports previous studies that suggest that epidural anesthesia is a significant
contributor to a prolonged second stage.11 and 12
There were differences in insurance type and fetal position between groups. We
analyzed both of these possible confounders and found that they had no interaction with
the results. The effects were in different directions for each insurance type and fetal
position. Thus, there does not appear to be confounding, but this is more likely effect
modification. The safety and effectiveness of prolonged second stage has been
evaluated previously only in retrospective studies. There are only 2 studies that
specifically report outcomes for nulliparous women with epidural anesthesia. 7 and 9 In 1
retrospective review that included 548 nulliparous women with prolonged second stage
and an epidural who were allowed to labor longer, the CD rate (17.9%) was comparable
with our extended labor results (19.5%). A second larger retrospective study of
3533 nulliparous women with prolonged second stage plus epidural who were allowed
to labor longer also confirmed a similar CD rate of 20.0%. In terms of maternal and
neonatal morbidities, this study showed rates of third- and fourth-degree laceration of
8.8%, postpartum hemorrhage of 7.3%, chorioamnionitis of 11.1%, endometritis of

1.2%, and a NICU admission rate of 7.1%. Importantly, our maternal and neonatal
complication incidences did not differ by group. However, our incidences of
chorioamnionitis and NICU admission in general were higher across both the extended
labor and usual labor groups than those found by prior studies, although the findings
were similar for the other outcomes. These findings could be explained by differences in
our study populations, but possibly they also reflect underreporting in retrospective data
vs our prospective data. Other retrospective studies of prolonged second stage are
difficult to compare with our data because the results are not stratified by epidural
status.
Extending the length of labor in nulliparous women with singleton gestations, epidural
anesthesia, and a prolonged second stage decreased the incidence of CD by slightly
more than one-half, compared with usual labor. Maternal or neonatal morbidity were not
statistically different between the groups, but our study was underpowered to detect
small but potentially clinical important differences. A larger trial would be necessary to
address further the safety of the extended protocol.
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Figure 1.
Consolidated Standards of Reporting Trials flow diagram
Flow diagram of study participants.
NFRHT, nonreassuring fetal heart tracing.
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet
Gynecol 2016.

Figure 2.
Delivery outcomes
Type of delivery by group.
CD, cesarean delivery; CI, confidence interval; OVD, operative vaginal delivery; RR, relative
risk; SVD, spontaneous vaginal delivery.
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet
Gynecol 2016.

Table 1.
Maternal, obstetric, and neonatal characteristics
Characteristics
Maternal age, ya
Epidural anesthesia, n (%)
Ethnicity (non-Hispanic), n (%)
Race, n (%)
Non-Hispanic white
Non-Hispanic black
Asian
Other
Insurance type, n (%)b
Private
Public or self pay
Pregnancy complications, n (%)
Gestational diabetes mellitus
Pregestational diabetes mellitus
Hypertensive disorder, n (%)
Chronic hypertension
Gestational hypertension
Preeclampsia
Body mass index at delivery, kg/m 2a
Prenatal weight gain, kga
Gestational age at delivery, wk a
Induction of labor, n (%)
Cervical ripening, n (%)
Dilation on admission, cm a
Oxytocin use, n (%)
Artificial rupture of membranes, n (%)
Contraction frequency in 2nd stage, mina
Supine position in 2nd stage, n (%)
Delayed pushing, n (%)
Patient willing to do operative vaginal delivery, n
(%)
Fetal position, n (%)c
Occiput anteriord
Occiput posteriore
Occiput transverse
Male fetus, n (%)

Extended labor (n =
41)
27.6 ± 4.7
41 (100)
37 (90.2)

Usual labor (n =
37)
28.7 ± 5.4
37 (100)
36 (97.3)

18 (43.9)
11 (26.8)
11 (26.8)
1 (2.4)

17 (45.9)
9 (24.3)
11 (29.7)
0

21 (51.2)
20 (48.8)

28 (75.7)
9 (24.3)

4 (9.8)
0

3 (8.1)
1 (2.7)

0
6 (14.6)
3 (7.3)
32.1 ± 6.2
15.2 ± 5.6
40.4 ± 0.9
22 (53.7)
11 (26.8)
3.0 ± 1.8
34 (82.9)
28 (68.3)
2.9 ± 1.0
38 (92.7)
34 (82.9)
36 (87.8)

2 (5.4)
2 (5.4)
3 (8.1)
29.5 ± 4.8
14.1 ± 6.2
40.0 ± 1.3
16 (43.2)
8 (21.6)
3.8 ± 1.7
30 (81.1)
17 (45.9)
3.3 ± 1.4
36 (97.3)
30 (81.1)
27 (73.0)

34 (82.9)
7 (17.1)
0
28 (68.3)

20 (54.1)
15 (40.5)
2 (5.4)
19 (51.4)

Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet
Gynecol 2016.
a. Data are given as mean ± standard deviation

b P = .03
c Across all 3 fetal positions, P = .015
d P = .01
e P = .03.

Incidence of CD was 19.5% in the extended labor group and 43.2% in the usual labor
group (relative risk [RR], 0.45; 95% confidence interval [CI], 0.22–
0.93; Table 2, Figure 2). The number needed to treat to prevent 1 CD was 4.2. SVD
was significantly increased in the extended labor group (RR, 2.71; 95% confidence
interval [CI], 1.30–5.62); OVD was not significantly different between groups (RR, 0.77;
95% CI, 0.41–1.45). When we analyzed FAVD (n = 5 in extended labor group and n = 3
in usual labor group) and VAVD (n = 7 in extended labor group and n = 11 in usual labor
group) separately, there was also no difference between groups (FAVD: RR, 1.50; 95%
CI, 0.39–5.86; VAVD: RR, 0.57; 95% CL, 0.25–1.32). Results were similar when
adjusted for confounders.

Table 2.
Maternal outcomes

Outcome
Cesarean delivery
Vaginal delivery
Spontaneous vaginal
delivery
Operative vaginal delivery
Chorioamnionitis
Endometritis
Postpartum hemorrhage
Transfusion
Third-/fourth-degree
perineal laceration
Cervical laceration

Extended labor
(n = 41), n (%)
8 (19.5)
33 (80.5)
21 (51.2)

Usual labor
(n = 37), n
(%)
16 (43.2)
21 (56.8)
7 (18.9)

12 (29.3)
11 (26.8)
1 (2.4)
8 (19.5)
1 (2.4)

14 (37.8)
13 (35.1)
1 (2.7)
3 (8.1)
0

6 (14.6)
0

Relative
risk
0.45
1.42
2.71

95% Confidence
interval
0.22–0.93a
1.03–1.95a
1.30–5.62a
0.41–1.45a
0.39–1.49a
0.06–13.92b
0.67–8.40b
Not estimable

1 (2.7)

0.77
0.76
0.90
2.41
Not
estimable
5.41

0

—

—

0.68–42.90b

Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet
Gynecol 2016.
a. Chi-square test
b. Fisher’s exact test.

Table 3.
Neonatal outcomes
Usual
labor ( n =
37)
0 (0)

Outcome
Shoulder dystocia, n (%)

Extended
labor (n = 41)
1 (2.4)

Birthweight, ga

3437 ± 527

Neonatal intensive care
unit admission, n (%)
Continuous positive
airway pressure or
greater, n (%)
Sepsis, n (%)
Seizure, n (%)
Umbilical artery cord pH
<7.10, n (%)
Perinatal death, n (%)
Neonatal intensive care
unit length of stay, da

13 (31.7)

3506 ±
534
14 (37.8)

1 (2.4)

Relative
risk
Not
estimable
—

95%
Confidence
interval
Not estimable

Pvalue
—

—

.6b

0.8

(0.46–1.54)

3 (8.1)

0.3

(0.03–2.77)

0
0
0

0
0
0

—
—
—

—
—
—

—
—
—

0
2.66 ± 1.02

0
4.03 ±
5.67

—
—

—
—

—
.3c

Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet
Gynecol 2016.
a Data are given as mean ± standard deviation
b Two sample t-test
c Wilcox Rank-Sum test.

